OBIO vs BHST โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
OBIO Captures Institutional Edge (2โ1 Pillars ยท 2โ6 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) driven by superior Momentum & Technical, Options & Structure while BHST counters with relative strength in Growth & Margin. Fundamentally, OBIO trades at N/M Forward P/E with -195.4% operating margin (-89.4% YoY revenue) versus BHST at N/M Forward P/E and -18.0% operating margin (+3.8% YoY). In options structure, OBIO sits in CONSOLIDATION (21st %ile IV; Dealer Gamma Walls on Pro) against BHST sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | OBIO Revenue | BHST Revenue | OBIO Op. Margin | BHST Op. Margin | Margin Edge |
|---|---|---|---|---|---|
| FY2022 | $0M | N/A | -924.3% | N/A | OBIO |
| FY2023 | $0M | $10M | -1866.2% | -78.6% | BHST |
| FY2024 | $0M | $30M | -2437.5% | -27.7% | BHST |
| FY2025 | $30M | $30M | -154.7% | -16.2% | BHST |
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OBIO | BHST | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $550.9M | $29.9M | Larger Scale | OBIO |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | -89.4% | +3.8% | Higher Growth | BHST |
| Operating Margin (TTM) Profitability | -195.4% | -18.0% | Higher Margin | BHST |
| Net Profit Margin Profitability | -182.5% | -31.2% | Higher Margin | BHST |
| Return on Equity (ROE) Capital Efficiency | -182.3% | -142.5% | Higher ROE | BHST |
| 52-Week Range Position Momentum | 72% ($3โ$8) | 6% ($1โ$7) | Stronger Trend | OBIO |
| Beta / 30D Volatility Risk Regime | 1.18ฮฒ ยท 88% Vol | 0.25ฮฒ ยท 86% Vol | Lower Realized Risk | BHST |
| Unified Institutional Score Composite Signal | 41.1 / 100 (SELL) | 58.2 / 100 (HOLD) | Higher Composite | BHST |